04.11.2014 Views

trans

trans

trans

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

420 DRUG RESISTANCE<br />

FIGURE 16.7 Drug <strong>trans</strong>port and targets in Trypanosoma brucei. Melarsoprol is taken up by the P2 adenosine<br />

<strong>trans</strong>porter. Mutations in P2 lead to reduced adenosine uptake and reduced melarsoprol uptake. The diamidines<br />

pentamidine and berenil are also taken up by P2, and mutations in P2 lead to reduced accumulation of pentamidine,<br />

although pentamidine is also taken up by high affinity (HAPT1) and low affinity (LAPT1) pentamidine <strong>trans</strong>porters.<br />

Eflornithine inhibits the enzyme ornithine decarboxylase (ODC). In eflornithine-resistant mutants the rate of<br />

ornithine uptake was augmented. Suramin is proposed to enter the cell bound to low density lipoprotein (LDL),<br />

through receptor-mediated endocytosis. The veterinary drug isometamidium is accumulated into the mitochondria,<br />

and resistance to this class of drug has been associated with changes in the mitochondrial electrical potential ().<br />

to melarsoprol refractoriness, but is not the<br />

only gene product involved. Other markers of<br />

resistance may correspond to ABC proteins.<br />

Indeed, several ABC <strong>trans</strong>porters have been<br />

described in T. brucei, and one gene highly<br />

similar to the Leishmania PGPA was recently<br />

cloned and <strong>trans</strong>fected in T. brucei and was<br />

shown to confer melarsoprol resistance. The<br />

mechanism by which it confers resistance<br />

(efflux, drug sequestration) is unknown, but<br />

it will be highly interesting to test whether<br />

mutations in this gene are correlated to melarsoprol<br />

resistance in clinical isolates. The availability<br />

of drug resistance markers could be used<br />

in diagnostic tests for evaluating resistance in<br />

the field.<br />

Eflornithine<br />

Eflornithine, or D, L--difluoromethylornithine<br />

(DFMO) is used against MelB refractory latestage<br />

T. b. gambiense infections. Its price and<br />

its availability limit its use in countries where<br />

infection is endemic. The drug, first developed<br />

as an anti-cancer agent, is a suicide inhibitor of<br />

the cellular enzyme ornithine decarboxylase<br />

(ODC), the limiting step in polyamine biosynthesis.<br />

Polyamines are essential for eukaryotic<br />

cell division and play a role in differentiation.<br />

Polyamines are also a component of trypanothione<br />

(Figure 16.6). Although DFMO is active<br />

against both the parasite and the host ODCs,<br />

its selective toxicity is the result of the longer<br />

MEDICAL APPLICATIONS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!